Literature DB >> 9015157

The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line.

F Xia1, H L Liber.   

Abstract

Abnormalities in the p53 gene play an important role in genomic instability and tumorigenesis. Our previous work showed that p53 status is correlated with differential mutability in two closely related human lymphoblastoid cell lines, TK6 and WTK1. WTK1 cells, which contain a mutation in p53 (p53Ile237) show a remarkably increased mutability, larger genetic alterations at the thymidine kinase locus (tk), an increased ability to catalyze recombination, and a delay in the onset of apoptosis after X-irradiation, compared to TK6 (p53 +/+). In the present study, we demonstrate that after transfection and subsequent overexpression of the known dominant negative mutant p53 Ala143 allele (mp53Ala143) in TK6, there were significantly enhanced spontaneous and X-ray-induced mutant frequencies at the tk locus, and delayed onset of X-ray-induced apoptosis, to a similar extent as in WTK1. In addition, high protein expression of mp53Ala143 in transfectants was correlated with both increased mutation frequency and altered apoptosis kinetics. Similar results were obtained with p53 Ile237 transfection into TK6. Our observations indicate that the product of the p53 gene affects mutational processes. We hypothesize that p53 dysfunction can lead to increased mutagenicity at the endogenous tk gene in human lymphoblastoid cell lines either through delayed apoptosis in response to DNA damage or by mediating increased recombination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015157     DOI: 10.1016/s0027-5107(96)00193-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.

Authors:  Charles B Simone; Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

2.  Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines.

Authors:  Tzu-Pin Lu; Liang-Chuan Lai; Be-I Lin; Li-Han Chen; Tzu-Hung Hsiao; Howard L Liber; John A Cook; James B Mitchell; Mong-Hsun Tsai; Eric Y Chuang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

3.  Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53.

Authors:  Chun-Qi Li; Laura J Trudel; Gerald N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

4.  Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers.

Authors:  Murilo M Pedrote; Michelle F Motta; Giulia D S Ferretti; Douglas R Norberto; Tania C L S Spohr; Flavia R S Lima; Enrico Gratton; Jerson L Silva; Guilherme A P de Oliveira
Journal:  iScience       Date:  2020-01-08

5.  Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways.

Authors:  Mark A Miles; Christine J Hawkins
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.